84 related articles for article (PubMed ID: 2272539)
21. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
23. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
24. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma.
Mazzaro C; Efremov DG; Burrone O; Pozzato G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):428-34. PubMed ID: 9789144
[TBL] [Abstract][Full Text] [Related]
27. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
28. [Membranoproliferative glomerulonephritis in non-Hodgkin's lymphoma nad myeloproliferative syndrome--a causal relationship?].
Gärtner HV; Arck P; Hanatani M; Settgast N; Wanninger R; Lederle RM; Erley C; Mikeler E
Verh Dtsch Ges Pathol; 1991; 75():229-34. PubMed ID: 1724839
[TBL] [Abstract][Full Text] [Related]
29. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
31. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
32. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
33. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
Schifferli JA; Morris SM; Dash A; Peters DK
Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
[TBL] [Abstract][Full Text] [Related]
34. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
Brandeis WE; Helson L; Wang Y; Good RA; Day NK
J Clin Invest; 1978 Dec; 62(6):1201-9. PubMed ID: 748375
[TBL] [Abstract][Full Text] [Related]
36. Circulating auto-antibodies in Ménière's disease.
Perez Garrigues H; Carmona E; Morera C; Sanchez-Cuenca JM
Ann Otolaryngol Chir Cervicofac; 1995; 112(5):225-8. PubMed ID: 7503502
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
38. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
39. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
